NYSE · CIK 0001306830
CE Celanese Corp
Insider trading from SEC Form 4. Last filing May 28, 2025. Close $45.02 on Oct 9, 2026, +27% from the 52-week low and -35% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
18
with a Form 4 at this company
Price and insider trades, last year
CEOct 9, 2026 · close 45.02
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Celanese Corp, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | Mark Christopher Murray SVP - Acetyls buy | $77k 1,479 shares | +11% | +40% from low-62% from high | |
| 52Moderate | Ganesh Moorthy director buy | $53k 1,000 shares | +50% | - | |
| 47Moderate | Deborah J. Kissire director buy | $54k 1,000 shares | +82% | - | |
| 47Moderate | Ganesh Moorthy director buy | $55k 1,000 shares | +100% | - | |
| 47Moderate | Mark Christopher Murray SVP - Acetyls buy | $128k 2,353 shares | +20% | - | |
| 56Moderate | Scott McDougald Sutton director buy | $407k 7,450 shares | +99% | - |
Transactions
The last 58 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 23, 2025 | Mark Christopher Murray SVP - Acetyls | POpen-market purchase Common Stock | +1,479 | $52.18 | $77k | 15,468 | May 28, 2025 |
| May 15, 2025 | Timothy Go director | DDisposition to issuer Common Stock | -1,114 | - | - | 3,376 | May 19, 2025 |
| May 15, 2025 | Michael Koenig director | FTax withholding Common Stock | -335 | $51.45 | $17k | 6,358 | May 19, 2025 |
| May 15, 2025 | Kim K.W. Rucker director | DDisposition to issuer Common Stock | -1,114 | - | - | 3,432 | May 19, 2025 |
| May 15, 2025 | Deborah J. Kissire director | DDisposition to issuer Common Stock | -1,114 | - | - | 4,476 | May 19, 2025 |
| May 15, 2025 | Kim K.W. Rucker director | AGrant or award Phantom Stockderivative | +1,114 | $0.00 | $0 | 9,501 | May 19, 2025 |
| May 15, 2025 | Timothy Go director | AGrant or award Phantom Stockderivative | +1,114 | $0.00 | $0 | 1,114 | May 19, 2025 |
| May 15, 2025 | Deborah J. Kissire director | AGrant or award Phantom Stockderivative | +1,114 | $0.00 | $0 | 5,913 | May 19, 2025 |
| May 9, 2025 | Edward G Galante director | AGrant or award Common Stock | +4,090 | $0.00 | $0 | 18,977 | May 13, 2025 |
| Jan 1, 2025 | Kathryn Hill director | CConversion Common Stock | +1,036 | $0.00 | $0 | 11,624 | May 13, 2025 |
| May 9, 2025 | Scott McDougald Sutton director | AGrant or award Common Stock | +3,376 | $0.00 | $0 | 18,376 | May 13, 2025 |
| May 9, 2025 | Kim K.W. Rucker director | AGrant or award Common Stock | +3,376 | $0.00 | $0 | 4,546 | May 13, 2025 |
| May 9, 2025 | Ganesh Moorthy director | AGrant or award Common Stock | +3,376 | $0.00 | $0 | 5,015 | May 13, 2025 |
| May 9, 2025 | Christopher J Kuehn director | AGrant or award Common Stock | +3,376 | $0.00 | $0 | 3,376 | May 13, 2025 |
| May 9, 2025 | Michael Koenig director | AGrant or award Common Stock | +3,376 | $0.00 | $0 | 6,693 | May 13, 2025 |
| May 9, 2025 | Deborah J. Kissire director | AGrant or award Common Stock | +3,376 | $0.00 | $0 | 5,590 | May 13, 2025 |
| May 9, 2025 | Jay Ihlenfeld V director | AGrant or award Common Stock | +3,376 | $0.00 | $0 | 15,850 | May 13, 2025 |
| May 9, 2025 | David F Hoffmeister director | AGrant or award Common Stock | +3,376 | $0.00 | $0 | 4,490 | May 13, 2025 |
| May 9, 2025 | Timothy Go director | AGrant or award Common Stock | +3,376 | $0.00 | $0 | 4,490 | May 13, 2025 |
| May 9, 2025 | Bruce E. Chinn director | AGrant or award Common Stock | +3,376 | $0.00 | $0 | 4,286 | May 13, 2025 |
| May 9, 2025 | Kathryn Hill director | AGrant or award Common Stock | +3,376 | $0.00 | $0 | 15,000 | May 13, 2025 |
| May 12, 2025 | Kim K.W. Rucker director | AGrant or award Phantom Stockderivative | +5 | $54.53 | $251 | 8,387 | May 13, 2025 |
| May 12, 2025 | Deborah J. Kissire director | AGrant or award Phantom Stockderivative | +3 | $54.53 | $144 | 4,799 | May 13, 2025 |
| May 12, 2025 | Jay Ihlenfeld V director | AGrant or award Phantom Stockderivative | +6 | $54.53 | $306 | 10,221 | May 13, 2025 |
| May 12, 2025 | Edward G Galante director | AGrant or award Phantom Stockderivative | +4 | $54.53 | $204 | 6,793 | May 13, 2025 |
| Jan 1, 2025 | Kathryn Hill director | CConversion Phantom Stockderivative | -1,036 | $0.00 | $0 | 2,942 | May 13, 2025 |
| May 12, 2025 | Kathryn Hill director | AGrant or award Phantom Stockderivative | +2 | $54.53 | $88 | 2,945 | May 13, 2025 |
| Mar 11, 2025 | Kathryn Hill director | AGrant or award Phantom Stockderivative | +2 | $54.61 | $88 | 2,943 | Mar 13, 2025 |
| Mar 11, 2025 | Kim K.W. Rucker director | AGrant or award Phantom Stockderivative | +5 | $54.61 | $251 | 8,382 | Mar 13, 2025 |
| Mar 11, 2025 | Jay Ihlenfeld V director | AGrant or award Phantom Stockderivative | +6 | $54.61 | $306 | 10,215 | Mar 13, 2025 |
| Mar 11, 2025 | Deborah J. Kissire director | AGrant or award Phantom Stockderivative | +3 | $54.61 | $144 | 4,796 | Mar 13, 2025 |
| Mar 11, 2025 | Edward G Galante director | AGrant or award Phantom Stockderivative | +4 | $54.61 | $204 | 6,790 | Mar 13, 2025 |
| Mar 12, 2025 | Ganesh Moorthy director | POpen-market purchase Common Stockindirect: By Ganesh and Hema Moorthy Revocable Living Trust | +1,000 | $53.29 | $53k | 3,000 | Mar 13, 2025 |
| Mar 7, 2025 | Deborah J. Kissire director | POpen-market purchase Common Stock | +1,000 | $54.28 | $54k | 2,214 | Mar 10, 2025 |
| Mar 7, 2025 | Ganesh Moorthy director | POpen-market purchase Common Stockindirect: By Ganesh and Hema Moorthy Revocable Living Trust | +1,000 | $54.67 | $55k | 2,000 | Mar 10, 2025 |
| Mar 7, 2025 | Mark Christopher Murray SVP - Acetyls | POpen-market purchase Common Stock | +2,353 | $54.45 | $128k | 13,989 | Mar 10, 2025 |
| Mar 7, 2025 | Scott McDougald Sutton director | POpen-market purchase Common Stock | +7,450 | $54.65 | $407k | 15,000 | Mar 10, 2025 |
| Feb 26, 2025 | Chuck Kyrish SVP & CFO | AGrant or award Nonqualified Stock Option (right to buy)derivative | +25,369 | $0.00 | $0 | 25,369 | Feb 28, 2025 |
| Feb 26, 2025 | Scott A Richardson CEO & President | AGrant or award Nonqualified Stock Option (right to buy)derivative | +95,137 | $0.00 | $0 | 95,137 | Feb 28, 2025 |
| Feb 26, 2025 | Aaron M McGilvray Chief Accounting Officer | AGrant or award Nonqualified Stock Option (right to buy)derivative | +2,114 | $0.00 | $0 | 2,114 | Feb 28, 2025 |
| Feb 26, 2025 | Mark Christopher Murray SVP - Acetyls | AGrant or award Nonqualified Stock Option (right to buy)derivative | +19,027 | $0.00 | $0 | 19,027 | Feb 28, 2025 |
| Feb 26, 2025 | Todd L Elliott SVP, EM | AGrant or award Nonqualified Stock Option (right to buy)derivative | +21,564 | $0.00 | $0 | 21,564 | Feb 28, 2025 |
| Feb 26, 2025 | Ashley B Duffie SVP & GC | AGrant or award Nonqualified Stock Option (right to buy)derivative | +17,124 | $0.00 | $0 | 17,124 | Feb 28, 2025 |
| Feb 15, 2025 | Chuck Kyrish SVP & CFO | AGrant or award Common Stock | +412 | $0.00 | $0 | 6,181 | Feb 19, 2025 |
| Feb 15, 2025 | Scott A Richardson CEO & President | AGrant or award Common Stock | +2,534 | $0.00 | $0 | 67,613 | Feb 19, 2025 |
| Feb 15, 2025 | Mark Christopher Murray SVP - Acetyls | AGrant or award Common Stock | +871 | $0.00 | $0 | 12,000 | Feb 19, 2025 |
| Feb 15, 2025 | Aaron M McGilvray Chief Accounting Officer | AGrant or award Common Stock | +158 | $0.00 | $0 | 6,016 | Feb 19, 2025 |
| Feb 15, 2025 | Ashley B Duffie SVP & GC | AGrant or award Common Stock | +412 | $0.00 | $0 | 14,009 | Feb 19, 2025 |
| Feb 15, 2025 | Aaron M McGilvray Chief Accounting Officer | FTax withholding Common Stock | -72 | $69.13 | $4,977 | 5,944 | Feb 19, 2025 |
| Feb 15, 2025 | Mark Christopher Murray SVP - Acetyls | FTax withholding Common Stock | -364 | $69.13 | $25k | 11,636 | Feb 19, 2025 |
| Feb 15, 2025 | Chuck Kyrish SVP & CFO | FTax withholding Common Stock | -267 | $69.13 | $18k | 5,914 | Feb 19, 2025 |
| Feb 15, 2025 | Scott A Richardson CEO & President | FTax withholding Common Stock | -964 | $69.13 | $67k | 66,649 | Feb 19, 2025 |
| Feb 15, 2025 | Ashley B Duffie SVP & GC | FTax withholding Common Stock | -174 | $69.13 | $12k | 13,835 | Feb 19, 2025 |
| Nov 13, 2024 | Edward G Galante director | AGrant or award Phantom Stockderivative | +64 | $74.00 | $4,706 | 6,786 | Nov 15, 2024 |
| Nov 13, 2024 | Kathryn Hill director | AGrant or award Phantom Stockderivative | +37 | $74.00 | $2,758 | 3,978 | Nov 15, 2024 |
| Nov 13, 2024 | Jay Ihlenfeld V director | AGrant or award Phantom Stockderivative | +96 | $74.00 | $7,080 | 10,210 | Nov 15, 2024 |
| Nov 13, 2024 | Deborah J. Kissire director | AGrant or award Phantom Stockderivative | +45 | $74.00 | $3,324 | 4,794 | Nov 15, 2024 |
| Nov 13, 2024 | Kim K.W. Rucker director | AGrant or award Phantom Stockderivative | +79 | $74.00 | $5,809 | 8,378 | Nov 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Bruce E. Chinndirector
- Ashley B DuffieSVP & GC
- Todd L ElliottSVP, EM
- Edward G Galantedirector
- Timothy Goceo, president, officer, director
- Kathryn Hilldirector
- David F Hoffmeisterdirector
- Jay Ihlenfeld Vdirector
- Deborah J. Kissiredirector
- Michael Koenigdirector
- Christopher J Kuehncfo, officer, director
- Chuck KyrishSVP & CFO
- Ganesh Moorthyceo, president, officer, director
- Aaron M McGilvrayChief Accounting Officer
- Mark Christopher MurraySVP - Acetyls
- Scott A RichardsonCEO & President
- Kim K.W. Ruckerdirector
- Scott McDougald Suttondirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.